Molecular mechanism
Amylin and calcitonin receptors
The calcitonin receptor, and the amylin receptor complexes it forms when associated with receptor activity-modifying proteins RAMP1, RAMP2 or RAMP3. Because the amylin receptors are heteromers rather than distinct gene products, receptor construct and accessory-protein expression must accompany any selectivity claim; a potency ranking is not transferable between assay systems.
01
Neutral molecular overview
The calcitonin receptor, and the amylin receptor complexes it forms when associated with receptor activity-modifying proteins RAMP1, RAMP2 or RAMP3. Because the amylin receptors are heteromers rather than distinct gene products, receptor construct and accessory-protein expression must accompany any selectivity claim; a potency ranking is not transferable between assay systems.
02
Target identifiers
- Gene symbols
- CALCR, RAMP1, RAMP2, RAMP3
03
Related compounds
Compound
Amylin (human IAPP)
Amylin is the endogenous 37-residue human pancreatic peptide hormone, co-secreted with insulin, from which pramlintide and cagrilintide are both derived.
Compound
Cagrilintide
Cagrilintide is a long-acting synthetic amylin analog, lipidated and disulfide-cyclized, characterised at the calcitonin receptor and at amylin receptor complexes.
Compound
Pramlintide
Pramlintide is an engineered analog of human amylin carrying three proline substitutions, designed to address the aggregation behaviour of the native human sequence.
04
Related mechanisms
No related mechanism is declared in this seed record.
05
Verified bibliography
- Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.current
Cao J, Belousoff MJ, Johnson RM, Keov P, Mariam Z, Deganutti G, Christopoulos G, Hick CA, Reedtz-Runge S, Glendorf T, Ballarín-González B, Raun K, Bayly-Jones C, Wootten D, Sexton PM
Nature communications · 2025-04-10 · Journal Article
- Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3.current
Carvas AO, Leuthardt A, Kulka P, Lommi G, Hassan S, Coester B, Lundh S, Pers T, Secher A, Raun K, Lutz TA, Le Foll C
EBioMedicine · 2025-07-03 · Journal Article
- Development of Cagrilintide, a Long-Acting Amylin Analogue.current
Kruse T, Hansen JL, Dahl K, Schäffer L, Sensfuss U, Poulsen C, Schlein M, Hansen AMK, Jeppesen CB, Dornonville de la Cour C, Clausen TR, Johansson E, Fulle S, Skyggebjerg RB, Raun K
Journal of medicinal chemistry · 2021-07-21 · Journal Article
06
Related glossary terms
07
Related Purely Peptides research articles
No existing Research Article is mapped to this mechanism seed record.